Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. [electronic resource]
Producer: 20160607Description: 2 p. digitalISSN:- 2050-6511
- Adult
- Aged
- Aged, 80 and over
- Anemia -- chemically induced
- Carboplatin -- administration & dosage
- Carrier Proteins -- genetics
- Colony-Stimulating Factors -- adverse effects
- DNA Repair -- genetics
- Female
- Genotype
- Hematinics -- adverse effects
- Humans
- Inactivation, Metabolic -- genetics
- Middle Aged
- Multidrug Resistance-Associated Protein 2
- Neurotoxicity Syndromes -- genetics
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Polymorphism, Single Nucleotide -- genetics
- Thrombocytopenia -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.